Search

Your search keyword '"Thiazolidinediones"' showing total 18,132 results

Search Constraints

Start Over You searched for: Descriptor "Thiazolidinediones" Remove constraint Descriptor: "Thiazolidinediones"
18,132 results on '"Thiazolidinediones"'

Search Results

1. Pioglitazone and asthma: a review of current evidence.

2. Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial.

3. Thiazolidinediones: Recent Development in Analytical Methodologies.

4. Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation.

5. Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence—A Narrative Review.

6. Development of natural perfume as potential fungicide candidates: construction and biological evaluation of vanillin analogs bearing the 1,3,4-oxadiazole/1,3-thiazolidin-4-one fragments.

7. Risk of Dementia and Alzheimer's Disease Associated With Antidiabetics: A Bayesian Network Meta-Analysis.

8. Cytotoxicity and toxicoproteomics analysis of thiazolidinedione exposure in human‐derived cardiomyocytes.

9. Glucose‐lowering drugs and liver‐related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population‐based studies.

10. Diabetic Osteodystrophy.

11. Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta‐analysis, and real‐world study from an international federated database

12. Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis.

13. Risk of Pancreatitis With Incretin Therapies Versus Thiazolidinediones in the Veterans Health Administration.

14. The optimal second-line therapy for older adults with type 2 diabetes mellitus: protocol for a systematic review and network meta-analysis using individual participant data (IPD).

15. Comparison of Quintuple Oral Anti-Diabetes Regimen with Standard Triple Oral Regimen in Managing Uncontrolled Type 2-Diabetes Mellitus: A Retrospective Controlled Cohort Study.

16. Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of N3‐Functionalized TZD‐Indole Conjugates as Potential Anticancer Agents.

17. Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus.

19. The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors

20. Long-term results of transferring the patient from therapy with glucagon-like peptide-1 receptor agonists in combination with metformin to a dipeptidyl peptidase-4 inhibitor in combination with pioglitazone and inhibitor of type 2 sodium-glucose cotransporter in type 2 diabetes

21. Researchers at Instituto Politecnico Nacional Target Phycobilisomes (Effect of * * Arthrospira maxima* * Phycobiliproteins, Rosiglitazone, and 17b-Estradiol on Lipogenic and Inflammatory Gene Expression during 3T3-L1 Preadipocyte Cell ...)

22. The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitntriors.

23. Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials.

24. Toxicometabolomics-based cardiotoxicity evaluation of Thiazolidinedione exposure in human-derived cardiomyocytes.

25. Molecular-level investigation of the adsorption mechanisms of thiazolidinediones on Cu2O(111) surface: a first-principles DFT study.

26. Associations Between Thiazolidinediones Use and Incidence of Rheumatoid Arthritis: A Retrospective Population‐Based Cohort Study.

27. Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches.

28. The effect of thiazolidinediones on body fat redistribution in adults: A systematic review and meta‐analysis of randomized controlled trials.

29. What is the role of pioglitazone for patients with type 2 diabetes in value-based care settings?

30. Use of Diabetes Medications before and after a Heart Failure–Related Hospitalization among Nursing Home Residents.

31. Vimentin protein is a factor for decreasing breast cancer cell proliferation co-culture with human bone marrow-derived mesenchymal stem cells pre-treated with thiazolidinedione solutions.

32. Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta‐analysis.

33. In Silico Studies of (Z)-3-(2-Chloro-4-Nitrophenyl)-5-(4-Nitrobenzylidene)-2-Thioxothiazolidin-4-One Derivatives as PPAR-γ Agonist: Design, Molecular Docking, MM-GBSA Assay, Toxicity Predictions, DFT Calculations and MD Simulation Studies.

34. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.

35. Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis.

36. Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition).

37. Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes

38. Effect of Dopamine Agonist Treatment on Glycemic Control in Patients with Lipodystrophy.

39. Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence—A Narrative Review

40. Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation

41. Antidiabetic Drugs in Breast Cancer Patients.

42. Unveiling the Link Between Low Handgrip Strength and Diabetic Foot Disease in Non-Geriatric Type 2 Diabetes Patients.

43. Detection of pioglitazone based on dual-emission ratiometric fluorescence probe consisting of ZIF8 and to L-ASC-AuNP/DA nanoparticles.

44. Adipose Tissue Dysfunction in Polycystic Ovary Syndrome.

45. Thiazolidinediones-PPAR-γ Agonists; for the treatment of Type II Diabetes Mellitus.

46. Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.

47. Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach.

48. Do oral antidiabetic medications alter the risk of Parkinson's disease? An updated systematic review and meta-analysis.

49. Comparison of the efficacy and safety of hypoglycemic treatments in patients with non-alcoholic fatty liver disease and type-2 diabetes: a systematic review and Bayesian network analysis.

Catalog

Books, media, physical & digital resources